SPECTRALIS Effective for Diagnosis and Education of Patients with Vitreous Opacities
In this video, Edwin H. Ryan Jr., MD highlights the efficacy of the SPECTRALIS for the imaging of vitreous opacities (floaters).

In this video, Edwin H. Ryan Jr., MD highlights the efficacy of the SPECTRALIS for the imaging of vitreous opacities (floaters).
A study of 50 patients with fibromyalgia and 232 healthy controls reported that the SPECTRALIS spectral-domain OCT was able to differentiate between controls and fibromyalgia patients.
Heidelberg Engineering, an industry partner of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), welcomes the unveiling of the consortium’s official website.
Josephine Evans, a specialist optometrist at the prestigious Moorfields Eye Hospital in London, UK, was honored for her work in exploring the relationship of morphology and function.
The Heidelberg Engineering Extreme Research Award 2022 has been presented to Dr. Bettina Hohberger for her diagnostic insights into long COVID.
A recent study of OCT changes in spaceflight-associated neuro-ocular syndrome (SANS) highlighted in the September 25th issue of Ocular Surgery News suggests that it may be possible for longer-duration lower body negative pressure (LBNP) application to reverse spaceflight-induced ocular changes.
Hear from Jim Williamson, OD, FAAO, Memphis VA Medical Center, as he discusses “Current and Emerging Anterior Segment Applications and Technology” on our recently recorded webinar.
Speaking at the 2022 American Society of Retina Specialists, Dr. Carl Danzig reported recent TRUCKEE study results demonstrating real-world safety and efficacy.
A new software modification for the SPECTRALIS enables noninvasive, in vivo imaging of the vitreous for the first time.
Dr. Farrell "Toby" Tyson overviews his pre-surgery cataract workup routine and discusses his preference of imaging with SPECTRALIS as part of his patient screening process.